| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1362052B1 Inhibitors of cruzipain and other cysteine proteases |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1267885B1 Male contraceptive formulation comprising norethisterone and testosterone undecanoate |
| 03/07/2007 | EP1255544B1 Mucin synthesis inhibitors |
| 03/07/2007 | EP1187811B1 Inhibitors of metalloproteinases |
| 03/07/2007 | EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS |
| 03/07/2007 | EP1032387B1 Novel metal complexes |
| 03/07/2007 | EP1003784B1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | EP0996444B1 Treatment of diabetes with thiazolidinedione and metformin |
| 03/07/2007 | EP0927062B1 Skin battery cosmetic composition |
| 03/07/2007 | EP0838221B1 Lyophilized hgf preparations |
| 03/07/2007 | EP0585242B2 Wound healing |
| 03/07/2007 | CN1925872A Method of preventing ultraviolet ray-induced apoptosis |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 03/07/2007 | CN1923813A Aporphine and use of oxidized aporphine alkaloid |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923272A Decoction medicine for treating chest sweat syndrome with deficiency of qi and blood in the heart and spleen and its preparation method |
| 03/07/2007 | CN1923259A Decoction medicine for treating chest sweat syndrome with heart kidney incoordination syndrome and its preparation method |
| 03/07/2007 | CN1923257A Decoction medicine for treating yin sweat syndrome with kidney yin deficiency syndrome and its preparation method |
| 03/07/2007 | CN1923254A Sheep placenta peptide preparation for promoting tissue renovation and preparing method thereof |
| 03/07/2007 | CN1923239A Umbilicus applying medicine for treating self sweat due yang deficiency of lung and kidney and its preparing process |
| 03/07/2007 | CN1923232A Medicine composition for dispersing pathogenic wind and extinguishing phlegm, absorbing clots and softening hard masses, preparation method and use thereof |
| 03/07/2007 | CN1923195A Application of cumarin kind compound in preparation of medicine for inducing nerve stem cell orienting differentiation |
| 03/07/2007 | CN1923187A Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 03/07/2007 | CN1303103C Transmembrane NFAT inhibitory peptide |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1302815C Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues |
| 03/07/2007 | CN1302811C Externally-applicated chewing gum including chip-like center |
| 03/07/2007 | CN1302798C Medicine for preventing and treating radiative damage |
| 03/07/2007 | CN1302796C Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
| 03/07/2007 | CN1302785C Health-care medicinal composition, and preparing method and use thereof |
| 03/07/2007 | CN1302779C Pharmaceutical preparation comprising abacavir and alovudine and use thereof |
| 03/07/2007 | CN1302777C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 03/07/2007 | CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/07/2007 | CN1302720C Dried meat of gastrodia tuber with low sugar |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186840 Quinoline derivatives as anti-inflammatory agents |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186836 Thienyl compounds |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186830 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 03/06/2007 | US7186819 Glutamate receptor and utilization thereof |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186798 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 03/06/2007 | US7186754 Use of creatine or creatine compounds for skin preservation |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186745 Angiogenesis inhibitors |
| 03/06/2007 | US7186741 Neurotensin active 2,3,diaryl-pyrazolidine derivatives |
| 03/06/2007 | US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186544 hexoses or their non-toxic salts or their intramolecular esterification products, particularly sodium gluconate, calcium gluconate or glucono delta lactone; promoting the growth of enterobacteria that short-chain fatty acids |
| 03/06/2007 | US7186528 Method for preparing a physiologically active IL-18 polypeptide |
| 03/06/2007 | US7186423 repeating solvent extraction using an alcohol, heating and extraction by water to obtain a residue having a stimulating effect on the production of lymphocytes, interleukens and macrophages; rhinitis; influenza; chronic fatigue syndrome; AIDS |
| 03/06/2007 | US7186418 Composition and use of RAR antagonists for promoting chondrogenesis |
| 03/06/2007 | US7186413 Hydrogels and water soluble polymeric carriers for drug delivery |
| 03/06/2007 | US7186411 Vaccines absorbable by the transmucosal way |
| 03/06/2007 | US7186407 Including claudication and critical limb ischemia, by administering fibroblast growth factor (FGF) in two doses, a single dose administered into each leg of the patient within one hour |
| 03/06/2007 | US7186401 comprises magnesium stearate for improved storage stability; inhalers |
| 03/06/2007 | CA2389264C Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 03/06/2007 | CA2312493C Novel suppository form comprising an acid-labile active compound |
| 03/06/2007 | CA2292895C Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2007 | CA2263961C Cocaine receptor binding ligands |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023768A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 03/01/2007 | WO2007023754A1 DRUG CONTAINING FBPase INHIBITOR |
| 03/01/2007 | WO2007023495A2 Method for production of single- and multi-layer microcapsules |
| 03/01/2007 | WO2006117624A3 Kynurenic acid and salts thereof for the prevention and treatment of shock |
| 03/01/2007 | WO2006085219A3 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 03/01/2007 | WO2006073711A3 Use of a matrix comprising a contrast agent in soft tissues |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049624 a mixture of 1-(4-hydroxyphenyl)-5-methylpyridin-2-one and pharmaceutically-acceptable excipients, used foro the treatment of liver fibrosis |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049607 Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents |
| 03/01/2007 | US20070049540 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049531 GLP-1 agonist and cardiovascular complations |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |